Literature DB >> 27622337

Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics.

Najoua Lalaoui, Kay Hänggi, Gabriela Brumatti, Diep Chau, Nhu-Y N Nguyen, Lazaros Vasilikos, Lisanne M Spilgies, Denise A Heckmann, Chunyan Ma, Margherita Ghisi, Jessica M Salmon, Geoffrey M Matthews, Elisha de Valle, Donia M Moujalled, Manoj B Menon, Sukhdeep Kaur Spall, Stefan P Glaser, Jennifer Richmond, Richard B Lock, Stephen M Condon, Raffi Gugasyan, Matthias Gaestel, Mark Guthridge, Ricky W Johnstone, Lenka Munoz, Andrew Wei, Paul G Ekert, David L Vaux, W Wei-Lynn Wong, John Silke.   

Abstract

Entities:  

Year:  2016        PMID： 27622337     DOI： 10.1016/j.ccell.2016.08.009

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


× No keyword cloud information.
  10 in total

1.  PD-L1 and IAPs co-operate to protect tumors from cytotoxic lymphocyte-derived TNF.

Authors:  Conor J Kearney; Najoua Lalaoui; Andrew J Freeman; Kelly M Ramsbottom; John Silke; Jane Oliaro
Journal:  Cell Death Differ       Date:  2017-06-30       Impact factor: 15.828

Review 2.  The resurrection of RIP kinase 1 as an early cell death checkpoint regulator-a potential target for therapy in the necroptosis era.

Authors:  Eunjin Ju; Kyeong Ah Park; Han-Ming Shen; Gang Min Hur
Journal:  Exp Mol Med       Date:  2022-09-28       Impact factor: 12.153

3.  Inhibition of MK2 suppresses IL-1β, IL-6, and TNF-α-dependent colorectal cancer growth.

Authors:  Anita L Ray; Kiersten L Berggren; Sebastian Restrepo Cruz; Gregory N Gan; Ellen J Beswick
Journal:  Int J Cancer       Date:  2017-12-12       Impact factor: 7.396

Review 4.  An overview of mammalian p38 mitogen-activated protein kinases, central regulators of cell stress and receptor signaling.

Authors:  Jiahuai Han; Jianfeng Wu; John Silke
Journal:  F1000Res       Date:  2020-06-29

Review 5.  The Regulation of JNK Signaling Pathways in Cell Death through the Interplay with Mitochondrial SAB and Upstream Post-Translational Effects.

Authors:  Sanda Win; Tin Aung Than; Neil Kaplowitz
Journal:  Int J Mol Sci       Date:  2018-11-20       Impact factor: 5.923

Review 6.  The p38 Pathway: From Biology to Cancer Therapy.

Authors:  Adrián Martínez-Limón; Manel Joaquin; María Caballero; Francesc Posas; Eulàlia de Nadal
Journal:  Int J Mol Sci       Date:  2020-03-11       Impact factor: 5.923

Review 7.  The p38 MAPK Components and Modulators as Biomarkers and Molecular Targets in Cancer.

Authors:  Laura García-Hernández; María Belén García-Ortega; Gloria Ruiz-Alcalá; Esmeralda Carrillo; Juan Antonio Marchal; María Ángel García
Journal:  Int J Mol Sci       Date:  2021-12-29       Impact factor: 5.923

8.  Modulating mitofusins to control mitochondrial function and signaling.

Authors:  Emmanouil Zacharioudakis; Bogos Agianian; Vasantha Kumar Mv; Nikolaos Biris; Thomas P Garner; Inna Rabinovich-Nikitin; Amanda T Ouchida; Victoria Margulets; Lars Ulrik Nordstrøm; Joel S Riley; Igor Dolgalev; Yun Chen; Andre J H Wittig; Ryan Pekson; Chris Mathew; Peter Wei; Aristotelis Tsirigos; Stephen W G Tait; Lorrie A Kirshenbaum; Richard N Kitsis; Evripidis Gavathiotis
Journal:  Nat Commun       Date:  2022-07-07       Impact factor: 17.694

Review 9.  Targeting apoptosis in acute myeloid leukaemia.

Authors:  Philippe A Cassier; Marie Castets; Amine Belhabri; Norbert Vey
Journal:  Br J Cancer       Date:  2017-08-24       Impact factor: 7.640

10.  RIPK1-mediated immunogenic cell death promotes anti-tumour immunity against soft-tissue sarcoma.

Authors:  Henry G Smith; Kunzah Jamal; Kevin J Harrington; Pascal Meier; Jasbani Hs Dayal; Tencho Tenev; Joan Kyula-Currie; Naomi Guppy; Patrycja Gazinska; Victoria Roulstone; Gianmaria Liccardi; Emma Davies; Ioannis Roxanis; Alan A Melcher; Andrew J Hayes; Gareth J Inman
Journal:  EMBO Mol Med       Date:  2020-05-18       Impact factor: 12.137
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.